Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer-Reference-Cited by-同舟云学术

Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer

Published:2021-01 Issue: Volume:296 Page:100240
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Asangani Irfan^ORCID,Blair Ian A.^ORCID,Van Duyne Gregory,Hilser Vincent J.,Moiseenkova-Bell Vera^ORCID,Plymate Stephen,Sprenger Cynthia,Wand A. Joshua,Penning Trevor M.^ORCID

Funder

U.S. Department of Defense

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference169 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2019

2. Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group;Sharifi;J. Urol.,1990

3. Nuclear receptors, RXR, and the big bang;Evans;Cell,2014

4. Steroid receptor coactivators 1, 2, and 3: Critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy;Johnson;Mol. Cell. Endocrinol.,2012

5. Mini-review: Foldosome regulation of androgen receptor action in prostate cancer;Querol Cano;Mol. Cell. Endocrinol.,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of SRC-3 in prostate cancer progression and implications for therapeutic targeting: A systematic review;Journal of Pharmacy & Pharmacognosy Research;2024-09-01

2. Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future;Medicinal Research Reviews;2024-08-22

3. Aldo-keto reductase (AKR) superfamily website and database: An update;Chemico-Biological Interactions;2024-08

4. Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs;Pharmaceuticals;2024-04-12

5. DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer;2023-11-25